Modern dental implant treatment has developed gradually over more than 50 yr. PER-INGVAR BR ANEMARK's discovery of osseointegration was based on observations of titanium chambers placed in rabbit bone, in the late 1950s, during a series of experiments (at the Lund University in Sweden) looking into microcirculation (1). BR ANEMARK's realization, some time later, that the implanted titanium objects had become directly connected to the bone, sparked the thought process that gave birth to the concept of osseointegration, which he then pursued in a systematic manner. The first patient was operated on by BR ANEMARK in 1965, according to what was to be termed the principle of osseointegration. However, the term 'osseointegration' was not used until 1977 (2) . At the same time, ANDR E SCHR € OEDER, in Switzerland, also worked on a titanium dental implant intended for clinical application based on a similar concept but these results were not published in English and thus were not as widely communicated at the time (3) .
Initially, colleagues and the wider scientific community were skeptical, if not hostile, of BR ANEMARK's findings because earlier dental implants had often failed and caused severe problems for patients. The turning point came in 1982, at the Toronto Osseointegration Conference. The research team at the Faculty of Dentistry, University of Toronto, led by Professor GEORGE ZARB, was the first outside Sweden to verify and replicate Br anemark's experiments on oral osseointegration, corroborating his findings. The 1982 conference is widely considered to be the point at which the evidence supporting osseointegration finally overcame any residual skepticism. The mainstream scientific and clinical acceptance of osseointegration thus had to wait almost 20 yr from the conception of the idea by BR ANEMARK (4) . At the time, the 'gold standard' implant system was the Br anemark System, manufactured by Nobel Pharma (later to become Nobel Biocare) and underpinned by evidence from a series of prospective multicenter studies carried out under the guidance of BR ANEMARK himself. Over the coming decade, increasing acceptance of implant dentistry led both to a widespread increase in its use and, in some cases, a dilution of the ideals underpinning it. Methodologies and protocols that had originally been strictly evidence-based and patient-focused became increasingly intertwined with commercial factors.
Most studies reporting on the long-term success of implant treatment show implant survival rates in the range of more than 95% after 10 yr in function (5) (6) (7) (8) (9) . It should, however, be recognized that many studies do not report on the occurrence of complications, either technical or biological, as shown in a systematic review by BERGLUNDH et al. (10) . suffer biological complications (11) , collectively termed peri-implant diseases. This topic has been explored extensively at a number of consensus meetings. In the 6th, 7th, and 8th European Workshop of Periodontology, The European Federation of Periodontology (EFP) defined peri-implant mucositis and peri-implantitis (12) (13) (14) . The term 'peri-implantitis' had first been used in 1965 by JACQUES LEVIGNAC in his article 'Periimplantation osteolysis -periimplantosis -periimplantitis' (15) . In that article, however, modern-type threaded implants were not yet in use. In 1987, MOM-BELLI et al. (16) suggested that 'periimplantitis be regarded as a site-specific infection'.
Scientific interest in the area of peri-implant biological complications has increased dramatically, especially over the last 10 yr, as evidenced by an increase in the number of publications and in the number of citations. By February 2018, according to the Web of Science, 1,932 articles were indexed with the key word 'periimplantitis' or 'peri-implantitis' (Fig. 1 ) and these articles had more than 43,000 citations, with almost 7,000 of these in 2017 (Fig. 2) . Given the increase in sales of implants and thus the accumulated number of implants installed in patients, an increase also in the presence of peri-implantitis could be expected.
Within the different specialist areas of dentistry and also in other contiguous disciplines, different perceptions of peri-implant biological complications occur, including in views regarding the prevalence/incidence of peri-implantitis. As there is no commonly accepted threshold for the extent of tissue changes/damage necessary for a diagnosis of peri-implantitis, the data presented on how common the disease is show large variation. Specifically, different surveys have used different criteria in terms of the extent of bone loss and probing pocket depth required for a peri-implantitis case definition (17) . This variation in criteria means that one study can report a prevalence of peri-implantitis of 50% or more, whereas another can report a significantly lower prevalence, of around 1%. In several studies the individual implant is used as the unit in reporting treatment outcomes, whereas other studies use the individual patient as the unit of analysis. Thus, because the same patient may have multiple implants, estimates of peri-implantitis prevalence may be very different depending on the unit of analysis. Moreover, the use of different cut-off points for the clinical registrations (i.e. bone loss, BOP, PPD) can lead to totally different values regarding the prevalence of periimplantitis in the same patient cohort, as demonstrated by KOLDSLAND et al. (18) (Fig. 3) .
Several systematic reviews and consensus documents have reported the prevalence of peri-implantitis to be in the order of 20% of all implant-treated patients and 10% of all implants (19) (20) (21) . As it is estimated that more than 12 million implants are installed annually on a global basis, this means that peri-implantitis develops, each year, in over 1 million implants. The estimated figures for Europe are presented in Fig. 4 ; however, the exact numbers are not known.
Comparing peri-implantitis with periodontitis
Peri-implant biological complications have many features in common with periodontal diseases, in terms of 
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clinical appearance and pathogenesis, while it is also largely accepted that they have a common etiology: the dysbiotic oral biofilm. Great similarities -but also some discrepancies -have indeed been identified in the biofilms from peri-implantitis and periodontitis sites (22) . Thus, in healthy conditions, the peri-implant microflora consists mainly of gram-positive cocci and non-motile bacilli, with only a small number of gramnegative anaerobic species, which is similar to the microflora at healthy teeth. In contrast, in peri-implant mucositis, increased numbers of cocci, motile bacilli, and spirochetes are observed, which is similar to gingivitis; whereas in peri-implantitis, increased numbers of gram-negative, motile, and anaerobic species are observed (including the three 'red complex' species Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola) which is similar to periodontitis. However, some microorganisms not commonly appearing in periodontitis sites, such as Staphylococcus aureus, Staphylococcus epidermidis, and Candida spp., have been identified in peri-implantitis sites (23) . Preclinical in vivo studies and clinical studies have clearly demonstrated that biofilm accumulation and maturation on implants leads to inflammation of peri-implant soft tissue -initially peri-implant mucositis appears and then later on peri-implantitis may develop, with rather similar histopathological and immunological characteristics to those seen during the development of gingivitis and periodontitis around teeth (24) (25) (26) (27) . Specifically, these studies have shown that established peri-implant lesions are characterized by an inflammatory infiltrate containing T-and B-cells, neutrophils, and macrophages, similarly to lesions around teeth but with the distinct differences that peri-implant lesions occupy a larger volume and contain a larger number of inflammatory cells compared with periodontal lesions, and periimplantitis lesions are localized closer to -or directly at -the bone, while there is always a zone of more healthy tissues between the inflammatory lesion and the bone in periodontitis lesions. Furthermore, as expected, it has been shown that molecular markers of inflammation are present at higher levels in peri-implant lesions than in healthy peri-implant tissues, similarly to observations when comparing periodontal inflammatory conditions with healthy conditions. It appears, however, that higher concentrations of inflammatory markers are observed in peri-implant lesions than in periodontal lesions (26, 28, 29) .
Alternative hypotheses have recently been presented regarding the etiopathogenesis of peri-implantitis, among which 'the foreign body' theory has received attention (30) . It is postulated that the infection seen at implants with peri-implantitis is a secondary event, following failure of osseointegration. Although the possibility should not be excluded that some (relatively few) implants may fail for reasons other than infection, it is currently broadly acknowledged that the majority of peri-implant lesions are of infectious etiology.
Peri-implant mucositis
To a great extent, peri-implant mucositis resembles gingivitis at natural teeth; it is defined as an inflammation of the soft tissues (i.e. the peri-implant mucosa) around an implant and clinically presents as bleeding upon gentle probing (13) . The condition is limited to the soft tissues, and peri-implant bone loss is not present. Biofilm accumulation is considered the main etiological factor (24, 25, 31, 32) and upon its removal, periimplant mucosal health can be achieved although complete resolution might not be expected in every case (26) . In addition to the microbial stimulus, smoking, the dimension of the keratinized tissue, systemic diseases (e.g. diabetes), and cement remnants are among the factors discussed as possible risk indicators for periimplant mucositis (33, 34) . The prevalence of periimplant mucositis at the patient level is reported to exceed 40% (35) . Typical clinical indications of periimplant mucositis are swelling and redness of the mucosa and bleeding upon gentle probing. As a result of the inflammation and swelling, the probing pocket depth might increase but without the occurrence of any bone loss; compared with natural teeth the periodontal probe might even penetrate more easily/deeper around implants in the presence of peri-implant mucositis (36, 37) . In general, probing pocket depths around dental implants often exceed 4 mm without the presence of any pathology. Hence, it is recommended to perform a baseline evaluation, including a periodontal pocket chart and radiographic assessment, at the time-point of prosthetic restoration to allow the long-term discrimination between peri-implant health and disease (38) (39) (40) . If the inflammation persists, the peri-implant bone may be affected in susceptible individuals and peri-implant bone loss may occur. There is increasing evidence that lack of regular supportive treatment in patients previously diagnosed with peri-implant mucositis might be associated with the progression of peri-implant mucositis into peri-implantitis (41).
Treatment of peri-implant mucositis
Treatment of peri-implant mucositis should include patient-and professionally administered plaque control. Both aim for mechanical disruption of the biofilm without altering the implant or abutment surface. Patientadministered plaque control can be delivered by manual or electric toothbrushes, interdental brushes, floss, and various special brushes. This mechanical approach can be supplemented by antimicrobial and/or antiseptic agents. However, the reported effect is often very limited or unclear and complete resolution of periimplant mucositis should not be expected solely by patient-administered plaque control (42) . Professionally administered plaque control (e.g. as delivered using an ultrasonic scaler with special tips, a plastic or titanium scaler, an air polishing device, or laser), with or without adjunctive chemical agents, can lead to a significant reduction in the degree of the peri-implant mucositis (i.e. reduced bleeding upon probing), but complete resolution -although possible -might not be expected in every case, no matter which treatment is used (43) . Hence, we should aim primarily for prevention of the development of peri-implant mucositis by improving the patient's oral hygiene, but also by providing the patient with a restoration that can actually be kept clean (44, 45) .
Peri-implantitis
Peri-implantitis (i.e. inflammation of the soft tissue at the implant with loss of supporting bone) corresponds to periodontitis at natural teeth and has, as the main clinical features, radiographic marginal bone loss, bleeding on probing and/or suppuration, and (most often) deepening of peri-implant pockets (13) (Fig. 5A,  B) . Similarly to periodontitis, additional clinical features may be swelling and redness of the soft tissue, although these are not always present; often, because of soft-tissue discoloration from the underlying implant, changes in the color of the overlying mucosa are not discernible. A large variation exists regarding the amount of bone loss that is considered necessary to define a case; in a pragmatic approach and in order to circumvent the problem that previous (baseline) radiographs are often missing, a threshold of ≥2 mm vertical bone loss from the expected marginal bone level following post-implant installation remodeling has been suggested in a recent consensus report (14) . Taking this threshold, peri-implantitis was recently reported to affect 14.5% of patients and 8% of implants about 9 yr after prosthetic rehabilitation (46) . Several risk factors/ indicators have been proposed for peri-implantitis, including (among others): history of periodontitis, untreated periodontitis, smoking, diabetes, insufficient maintenance care, non-specialists providing the prosthetic therapy, excess cement, and bone-level implant design (46, 47) . Untreated periodontitis and a history of periodontitis is, of course, of importance from a clinicians' perspective because it has been shown that patients with properly treated periodontitis (i.e. with no or very few residual moderately deep pockets at the time of implant installation) do not have a higher risk for peri-implantitis compared with non-periodontitis-susceptible individuals, while patients with residual periodontal pockets at the time of implant installation have a risk for peri-implantitis that is three to four times higher than that of non-susceptible individuals or successfully treated periodontitis patients (48, 49) . Furthermore, it has been demonstrated that periodontitis patients have significantly reduced risk for peri-implantitis and/or implant loss over a 10-yr period when compliant with a systematic supportive periodontal therapy (SPT) scheme, compared with patients with erratic SPT attendance (50, 51) .
Management of peri-implantitis
As all peri-implantitis lesions are characterized by the presence of a dysbiotic biofilm, current therapeutic schemes are based on anti-infective concepts. 
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Obviously, the main goal of peri-implantitis treatment is controlling the infection and arresting progression of bone loss -if possible without compromising estheticsand achieving bone regeneration, ideally including implant re-osseointegration. Indeed, preclinical studies have shown that re-osseointegration on a previously contaminated implant surface is possible, although not predictably so (52) . The paradigm of periodontitis treatment management of peri-implantitis includes measures such as oral hygiene, non-surgical debridement, reconstructive surgical procedures when needed, and supportive treatment (53) . It is currently accepted that the success of non-surgical treatment of peri-implantitis is unpredictable and, irrespective of the type/means of instrumentation or use of any adjuncts, it yields limited improvements (in probing-depth reduction and clinical attachment level gain) compared with baseline. In particular, a recent systematic review concluded that although mechanical debridement with adjunct chemotherapeutic means (antibiotic or antiseptics) may have a small added effect over mechanical debridement alone, no non-surgical approach could be recommended as superior to any other such approach (54) . Non-surgical treatment is thus considered as an indispensable part of peri-implantitis management although it has limited effect in terms of controlling the disease, especially in moderate and advanced cases (45, 55) .
Therefore, in the vast majority of peri-implantitis cases, surgery follows shortly after non-surgical treatment. In a network meta-analysis, it has indeed been observed that surgical treatment generally yields larger clinical improvements compared with non-surgical treatment (56) . As ineffectiveness of non-surgical therapy is mainly attributed to the inefficient removal of biofilm from the complex implant surface, the main aim of surgical peri-implantitis therapy is to provide access for the effective reduction (ideally elimination) of the biofilm. A variety of means, both mechanical (e.g. carbon curettes, titanium curettes, titanium brushes) and chemical (e.g. NaCl solution, chlorhexidine, iodine, hydrogen peroxide), usually as combinations, have been used for decontamination of the implant surface. However, based on systematic reviews of in-vitro studies, no means have demonstrated the possibility to eliminate the biofilm completely (57, 58) , just as systematic reviews of preclinical and clinical studies have failed to show superiority of any specific decontamination method (solo or combination approaches) in terms of histological and/or clinical outcomes (52, 59, 60) . One method that can dramatically alter microbial contamination of the implant surface is its mechanical modification (grinding) by means of rotating instruments -a method termed implantoplasty. The rationale behind implantoplasty is that removal of the threads and roughening of the implant surface leads to removal of the biofilm, while recolonization of the altered (smoother) implant surface is reduced. In this context, it has become apparent from preclinical in vivo studies that the implant surface per se can influence both the rate of peri-implantitis progression and the outcome of peri-implantitis surgery (61, 62) . In particular, variation in the implant surface microtopography was associated with a variable amount of residual inflammation postoperatively and consequently with bone regeneration, with turned/machined implant surfaces exhibiting the healthiest peri-implant tissues postoperatively (62) . Implantoplasty, in combination with apically repositioned beveled flap and bone recontouring, has indeed been shown to result in larger and relevant clinical improvements, which remained stable for at least 3 yr, compared with no modification of the implant surface (63) . On the other hand, it has been demonstrated that rough implants have a better potential for re-osseointegration compared with turned/machined implants after efficient surface decontamination and grafting, provided that there are residual bone walls in the proximity of the implant (52, 64) . Thus, current approaches take into account the peri-implant defect morphology, implant surface characteristics, and esthetic needs, and regard resective techniques, regenerative techniques, or combinations thereof; however, based on currently available evidence, no technique can be suggested as superior to any other (45, 53) . In a recent systematic review of surgical peri-implantitis treatment, resolution of the lesion (i.e. no bleeding on probing and probing depth ˂5 mm) was achieved in about 75% of cases (based on data from about 500 implants) (65) . However, despite this relatively optimistic information, there are cases in which the only sensible treatment is explantation of the implant. A relevant issue is whether periimplantitis surgery should be combined with systemic antibiotics; however, data are scarce. In a recent consensus report, use of antibiotics was advocated based on a better-safe-than-sorry approach (65) . Nevertheless, in a recent study, significantly better outcomes were observed in rough implants subjected to peri-implantitis surgery with systemic antibiotics, whereas systemic antibiotics did not seem to have any relevant effect in cases of machined/polished implants (66) . Currently, there is limited knowledge about the long-term outcome of peri-implantitis treatment. In two recently published studies, the clinical improvements obtained after peri-implantitis treatment were preserved over 5 yr in the majority of implants in patients with high standards of oral hygiene and following a supportive therapy scheme (67, 68) .
Concluding remarks
Peri-implantitis is indeed a challenge for the profession, from an etiologic, diagnostic, and therapeutic perspective. We should, however, not lose perspective; the introduction of dental implants into our therapeutic arena has added treatment possibilities that earlier were not available or feasible. Implants have added to the quality of life for millions of patients. A natural dentition may suffer from caries, periodontitis, and other diseases, occasionally leading to the loss of teeth. Likewise, dental implants may have shortcomings from both technical and biologic perspectives, but in the vast majority of patients the implant treatment will lead to long-term success. Both periodontitis and peri-implantitis have many different disease definitions, leading to varying figures regarding the true burden of the conditions. Although evidence supports an essential role of microbes in both periodontitis and peri-implantitis, the disease severity is not a simple function of the extent and duration of the bacterial challenge, and/or qualitative microbial differences. Lessons from periodontology have taught us that not every individual is equally susceptible to periodontitis (69) . It is likely that this lesson is also fully valid regarding peri-implantitis.
